Molecular Basis of Genetic Neuropsychiatric Disorders

Child and Adolescent Psychiatric Clinics of North America

Volumn 16, Issue 3, 2007, Pages 541-556

  Venkitaramani, Deepa V ^a   Lombroso, Paul J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; FRAGILE X MENTAL RETARDATION PROTEIN; GUANINE; METHYL CPG BINDING PROTEIN 2; UBIQUITIN PROTEIN LIGASE;

ALLELE; CHILD PSYCHIATRY; CHROMOSOME DELETION; CLINICAL FEATURE; CYTOGENETICS; EXTRACHROMOSOMAL INHERITANCE; FRAGILE X SYNDROME; GENE CONTROL; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC DISORDER; GENOME IMPRINTING; HAPPY PUPPET SYNDROME; HUMAN; METHYLATION; MOLECULAR GENETICS; NEUROPSYCHIATRY; PHENOTYPE; POINT MUTATION; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RETT SYNDROME; REVIEW; RNA BINDING; RNA TRANSLATION; TISSUE DIFFERENTIATION;

ANGELMAN SYNDROME; BRAIN; CHROMOSOMES, HUMAN, X; HUMANS; MENTAL DISORDERS; MENTAL RETARDATION; PRADER-WILLI SYNDROME;

EID: 34249986673     PISSN: 10564993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chc.2007.03.003     Document Type: Review

References (76)

1. Kandel E.R. A new intellectual framework for psychiatry. Am J Psychiatry 155 (1998) 457-469
2. Neslter E.J., Barrot M., DiLeone R.J., et al. Neurobiology of depression. Neuron 34 (2002) 13-25
3. Abelson J.F., Kwan K.Y., O'Roak B.J., et al. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310 (2005) 317-320
4. Gupta AR, State MW. Recent advances in the genetics of autism. Biol Psychiatry. 2007;61:429-37.
5. Bagni C., and Greenough W.T. From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nat Rev Neurosci 6 (2005) 376-387
6. Lubs H. A marker X chromosome. Am J Hum Gen 21 (1969) 231-244
7. Fu Y.H., Kuhl D.P., Pizzuti A., et al. Variation of the CGG repeat at the fragile site results in genetic instability: resolution of the Sherman paradox. Cell 67 (1991) 1047-1058
8. Hagerman R.J., Staley L.W., O'Conner R., et al. Learning-disabled males with a fragile X CGG expansion in the upper premutation size range. Pediatrics 97 (1996) 122-126
9. de von Flindt R., Bybel B., Chudley A.E., et al. Short-term memory and cognitive variability in adult fragile X females. Am J Med Genet 38 (1991) 488-492
10. Kemper M., Hagerman R., Ahmad R., et al. Cognitive profiles and the spectrum of clinical manifestations in heterozygous fra(X) females. Am J Med Genet 23 (1986) 139-156
11. Murphy D.G., Mentis M.J., Pietrini P., et al. Premutation female carriers of fragile X syndrome: a pilot study on brain anatomy and metabolism. J Am Acad Child Adolesc Psychiatry 38 (1999) 1294-1301
12. Allingham-Hawkins D.J., Babul-Hirji R., Chitayat D., et al. Fragile X premutation is a significant risk factor for premature ovarian failure: The Iinternational Collaborative POF in Fragile X Study- preliminary data. Am J Med Genet 83 (1999) 322-325
13. Jacquemont S., Hagerman R.J., Leehey M.A., et al. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. J Am Med Assoc 291 (2004) 460-469
14. Jacquemont S., Leehey M.A., Hagerman R.J., et al. Size bias of fragile X premutation alleles in late-onset movement disorders. J Med Genet 43 (2006) 804-809
15. Hagerman P.J., and Hagerman R.J. Fragile X-associated tremor/ataxia syndrome (FXTAS). Ment Retard Dev Disabil Res Rev 10 (2004) 25-30
16. Nelson D. The fragile X syndromes. Semin Cell Biol 6 (1995) 5-11
17. Oberle I., Rousseau F., Heitz D., et al. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252 (1991) 1097-1110
18. Pieretti M., Zhang F., Fu Y.-H., et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66 (1991) 817-822
19. Eichler E.E., Richards S., Gibbs R.A., et al. Fine structure of the human FMR1 gene. Hum Mol Genet 2 (1993) 1147-1153
20. Siomi H., Siomi M., Nussbaum R., et al. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell 74 (1993) 291-298
21. Siomi H., Choi M., Siomi M.C., et al. Essential role for KH domains in RNA binding: impaired RNA binding mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell 77 (1994) 33-39
22. De Boulle K., Verkerk A.J., Reyniers E., et al. A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat Genet 3 (1992) 31-35
23. Musco G., Stier G., Joseph C., et al. Three dimensional structure and stability of the KH domain: molecular insights into the fragile X syndrome. Cell 85 (1996) 237-245
24. Khandjan E.W., Corbin F., Woerly S., et al. The fragile X mental retardation protein is associated with ribosomes. Nat Genet 12 (1996) 91-93
25. Abitbol M., Menini C., Delezoide A.L., et al. Nucleus basalis magno cellularis and hippocampus are the major sites of FMR-1 expression in human fetal brain. Nat Genet 4 (1993) 147-152
26. Mostofsky S.H., Mazzocco M.M., Aakalu G., et al. Decreased cerebellar posterior vermis size in fragile X syndrome: correlation with neurocognitive performance. Neurology 50 (1998) 121-130
27. Mostofsky S.H., Reiss A.L., Lockhart P., et al. Evaluation of cerebellar size in attention-deficit hyperactivity disorder. J Child Neurol 13 (1998) 434-439
28. Reiss A.L., Lee J., and Freund L. Neuroanatomy of fragile X syndrome: the temporal lobe. Neurology 44 (1994) 1317-1324
29. Dutch-Belgian Fragile X Consortium. FMR-1 knock out mice: a model to study fragile X mental retardation. Cell 78 (1994) 23-33
30. Steward O., and Schuman E.M. Protein synthesis at synaptic sites on dendrites. Annu Rev Neurosci 24 (2001) 299-325
31. Ostroff L.E., Fiala J.C., Allwardt B., et al. Polyribosomes redistribute from dendritic shafts into spines with enlarged synapses during LTP in developing rat hippocampal slices. Neuron 35 (2002) 535-545
32. Brown V., Jin P., Ceman S., et al. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107 (2001) 477-487
33. Darnell J.C., Jensen K.B., Jin P., et al. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107 (2001) 489-499
34. Zalfa F., Giorgi M., Primerano B., et al. The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 112 (2003) 317-327
35. Kelleher R.J., Govindarajan A., and Tonegawa S. Translational regulatory mechanisms in persistent forms of synaptic plasticity. Neuron 44 (2004) 59-73
36. Kelleher R.J., Govindarajan A., Jung H.Y., et al. Translational control by MAPK signaling in long-term synaptic plasticity and memory. Cell 116 (2004) 467-479
37. Irwin S.A., Patel B., Idupulapati M., et al. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am J Med Genet 98 (2001) 161-167
38. Comery T.A., Harris J.B., Willems P.J., et al. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci USA 94 (1997) 5401-5404
39. Caskey C.T., Pizzuti A., Fu Y.H., et al. Triplet repeat mutations in human disease. Science 256 (1992) 784-789
40. Nelson D., and Warren S. Trinucleotide repeat instability: when and where?. Nat Genet 4 (1993) 107-108
41. Warren S. The expanding world of trinucleotide repeats. Science 271 (1996) 1374-1375
42. Fu Y.H., Pizzuti A., Fenwick Jr. R.G., et al. An unstable triplet repeat in a gene related to myotonic dystrophy. Science 255 (1992) 1256-1258
43. Isles A.R., and Humby T. Modes of imprinted gene action in learning disability. J Intellect Disabil Res 50 (2006) 318-325
44. Prader A., Labhart A., and Willi H. A syndrome of adiposity, small stature, cryptorchism, mental retardation and hypotonia in new-born infants. [German]. Schweiz Med Wschenschr 86 (1956) 1260-1261
45. Holm V.A., Cassidy S.B., Butler M.G., et al. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 91 (1993) 398-402
46. Dykens E.M., and Cassidy S.B. Correlates of maladaptive behavior in children and adults with Prader-Willi syndrome. Am J Med Genet 60 (1995) 546-549
47. Dykens E.M., Leckman J.F., and Cassidy S.B. Obsessions and compulsions in Prader-Willi syndrome. J Child Psychol Psychiatry 37 (1996) 995-1002
48. State M.W., Dykens E.M., Rosner B., et al. Obsessive-compulsive symptoms in Prader-Willi and "Prader-Willi-like" patients. J Am Acad Child Adolesc Psychiatry 38 (1999) 329-334
49. Angelman H. 'Puppet children' a report of three cases. Dev Med Child Neurol 7 (1965) 681-688
50. Ledbetter D.H., Riccardi V.M., Airhart S.D., et al. Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. N Engl J Med 304 (1981) 325-329
51. Magenis R.E., Brown M.G., Lacy D.A., et al. Is Angelman syndrome an alternate result of del(15)(q11q13)?. Am J Med Genet 28 (1987) 829-838
52. Cassidy S.B., and Schwartz S. Prader-Willi and Angelman syndromes: disorders of genomic imprinting. Medicine 77 (1998) 140-151
53. Cassidy S.B. Prader-Willi syndrome. J Med Genet 34 (1997) 917-923
54. Nicholls R.D., Saitoh S., and Horsthemke B. Imprinting in Prader-Willi and Angelman syndromes. Trends Genet 14 (1998) 194-200
55. Ledbetter D., and Engel E. Uniparental disomy in humans: development of an imprinting map and its implications for prenatal diagnosis. Hum Mol Genet 4 (1995) 1757-1764
56. Nicholls R.D., Knoll J.H., Butler M.G., et al. Genetic imprinting suggested by maternal heterodisomy in non-deletion Prader-Willi syndrome. Nature 342 (1989) 281-285
57. Ohta T., Gray T.A., Rogan P.K., et al. Imprinting-mutation mechanisms in Prader-Willi syndrome. Am J Hum Genet 64 (1999) 397-413
58. Buiting K., Barnicoat A., Lich C., et al. Disruption of the bipartite imprinting center in a family with Angelman syndrome. Am J Hum Genet 68 (2001) 1290-1294
59. Kishino T., Lalande M., and Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet 15 (1997) 70-73
60. Matsuura T., Sutcliffe J.S., Fang P., et al. Novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet 15 (1997) 74-77
61. Nicholls R.D. Strange bedfellows? Protein degradation and neurological dysfunction. Neuron 21 (1998) 647-649
62. Albrecht U., Sutcliffe J.S., Cattanach B.M., et al. Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nat Genet 17 (1997) 75-78
63. A receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J Neurosci 18 (1998) 8505-8514
64. Rett A. On a unusual brain atrophy syndrome in hperammonemia in childhood. [German]. Wien Med Wochenschr 116 (1966) 723-726
65. Naidu S. Rett syndrome: natural history and underlying disease mechanisms. Eur Child Adolesc Psychiatry 6 (1997) 14-17
66. Webb T., Clarke A., Hanefeld F., et al. Linkage analysis in Rett syndrome families suggests that there may be a critical region at Xq28. J Med Genet 35 (1998) 997-1003
67. Amir R.E., Van den Veyver I.B., Wan M., et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23 (1999) 185-188
68. Kass S.U., Pruss D., and Wolffe A.P. How does DNA methylation repress transcription?. Trends Genet 13 (1997) 444-9
69. Neul J.L., and Zoghbi H.Y. Rett syndrome: a prototypical neurodevelopmental disorder. Neuroscientist 10 (2004) 118-128
70. Nan X., Campoy F.J., and Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88 (1997) 471-481
71. Park W.J., Meyers G.A., Li X., et al. Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability. Hum Mol Genet 4 (1995) 1229-1233
72. Weaving L.S., Christodoulou J., Williamson S.L., et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet 75 (2004) 1079-1093
73. Evans J.C., Archer H.L., Colley J.P., et al. Early onset seizures and Rett-like features associated with mutations in CDKL5. Eur J Hum Genet 13 (2005) 1113-1120
74. Borg I., Freude K., Kubart S., et al. Disruption of Netrin G1 by a balanced chromosome translocation in girl with Rett syndrome. Eur J Hum Genet 13 (2005) 921-927
75. Lifton R.P. Molecular genetics of human blood pressure variation. Science 272 (1996) 676-680
76. Miki Y., Swensen J., Shattuck-Eidens D., et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266 (1994) 66-71